These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 19730858)
1. An additional ORF on meloe cDNA encodes a new melanoma antigen, MELOE-2, recognized by melanoma-specific T cells in the HLA-A2 context. Godet Y; Moreau-Aubry A; Mompelat D; Vignard V; Khammari A; Dreno B; Lang F; Jotereau F; Labarriere N Cancer Immunol Immunother; 2010 Mar; 59(3):431-9. PubMed ID: 19730858 [TBL] [Abstract][Full Text] [Related]
2. MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency. Godet Y; Moreau-Aubry A; Guilloux Y; Vignard V; Khammari A; Dreno B; Jotereau F; Labarriere N J Exp Med; 2008 Oct; 205(11):2673-82. PubMed ID: 18936238 [TBL] [Abstract][Full Text] [Related]
3. Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy. Godet Y; Desfrançois J; Vignard V; Schadendorf D; Khammari A; Dreno B; Jotereau F; Labarrière N Eur J Immunol; 2010 Jun; 40(6):1786-94. PubMed ID: 20217862 [TBL] [Abstract][Full Text] [Related]
4. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone. Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931 [TBL] [Abstract][Full Text] [Related]
5. MELOE-1 antigen contains multiple HLA class II T cell epitopes recognized by Th1 CD4+ T cells from melanoma patients. Bobinet M; Vignard V; Rogel A; Khammari A; Dreno B; Lang F; Labarriere N PLoS One; 2012; 7(12):e51716. PubMed ID: 23284752 [TBL] [Abstract][Full Text] [Related]
6. A long peptide from MELOE-1 contains multiple HLA class II T cell epitopes in addition to the HLA-A*0201 epitope: an attractive candidate for melanoma vaccination. Rogel A; Vignard V; Bobinet M; Labarriere N; Lang F Cancer Immunol Immunother; 2011 Mar; 60(3):327-37. PubMed ID: 21080167 [TBL] [Abstract][Full Text] [Related]
7. Use of an in vitro immunoselected tumor line to identify shared melanoma antigens recognized by HLA-A*0201-restricted T cells. Harada M; Li YF; El-Gamil M; Rosenberg SA; Robbins PF Cancer Res; 2001 Feb; 61(3):1089-94. PubMed ID: 11221837 [TBL] [Abstract][Full Text] [Related]
8. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles. Kawakami Y; Robbins PF; Wang X; Tupesis JP; Parkhurst MR; Kang X; Sakaguchi K; Appella E; Rosenberg SA J Immunol; 1998 Dec; 161(12):6985-92. PubMed ID: 9862734 [TBL] [Abstract][Full Text] [Related]
9. T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines. Shilyansky J; Nishimura MI; Yannelli JR; Kawakami Y; Jacknin LS; Charmley P; Rosenberg SA Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2829-33. PubMed ID: 7511820 [TBL] [Abstract][Full Text] [Related]
10. Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma. Kawakami Y; Dang N; Wang X; Tupesis J; Robbins PF; Wang RF; Wunderlich JR; Yannelli JR; Rosenberg SA J Immunother; 2000 Jan; 23(1):17-27. PubMed ID: 10687134 [TBL] [Abstract][Full Text] [Related]
11. Recognition of shared melanoma antigen by HLA-A2-restricted cytolytic T cell clones derived from human tumor-infiltrating lymphocytes. Viret C; Davodeau F; Guilloux Y; Bignon JD; Semana G; Breathnach R; Jotereau F Eur J Immunol; 1993 Jan; 23(1):141-6. PubMed ID: 8419164 [TBL] [Abstract][Full Text] [Related]
12. Peptide-specific CTL in tumor infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and Tyrosinase genes: a study in an unselected group of HLA-A2.1-positive patients. Spagnoli GC; Schaefer C; Willimann TE; Kocher T; Amoroso A; Juretic A; Zuber M; Luscher U; Harder F; Heberer M Int J Cancer; 1995 Oct; 64(5):309-15. PubMed ID: 7591302 [TBL] [Abstract][Full Text] [Related]
13. TCR Analyses of Two Vast and Shared Melanoma Antigen-Specific T Cell Repertoires: Common and Specific Features. Simon S; Wu Z; Cruard J; Vignard V; Fortun A; Khammari A; Dreno B; Lang F; Rulli SJ; Labarriere N Front Immunol; 2018; 9():1962. PubMed ID: 30214446 [TBL] [Abstract][Full Text] [Related]
14. The melanoma antigens MELOE-1 and MELOE-2 are translated from a bona fide polycistronic mRNA containing functional IRES sequences. Carbonnelle D; Vignard V; Sehedic D; Moreau-Aubry A; Florenceau L; Charpentier M; Mikulits W; Labarriere N; Lang F PLoS One; 2013; 8(9):e75233. PubMed ID: 24086473 [TBL] [Abstract][Full Text] [Related]
15. A novel melanoma gene (MG50) encoding the interleukin 1 receptor antagonist and six epitopes recognized by human cytolytic T lymphocytes. Mitchell MS; Kan-Mitchell J; Minev B; Edman C; Deans RJ Cancer Res; 2000 Nov; 60(22):6448-56. PubMed ID: 11103812 [TBL] [Abstract][Full Text] [Related]
16. A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes. Schiavetti F; Thonnard J; Colau D; Boon T; Coulie PG Cancer Res; 2002 Oct; 62(19):5510-6. PubMed ID: 12359761 [TBL] [Abstract][Full Text] [Related]
17. Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients. Serana F; Sottini A; Caimi L; Palermo B; Natali PG; Nisticò P; Imberti L J Transl Med; 2009 Mar; 7():21. PubMed ID: 19317896 [TBL] [Abstract][Full Text] [Related]
18. Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes. Robbins PF; el-Gamil M; Li YF; Topalian SL; Rivoltini L; Sakaguchi K; Appella E; Kawakami Y; Rosenberg SA J Immunol; 1995 Jun; 154(11):5944-50. PubMed ID: 7751637 [TBL] [Abstract][Full Text] [Related]
19. [Human melanoma-specific peptide antigens recognized by HLA-A2 restricted tumor-infiltrating lymphocytes]. Ge H; Bao Z Zhonghua Yi Xue Za Zhi; 1996 Sep; 76(9):658-61. PubMed ID: 9275546 [TBL] [Abstract][Full Text] [Related]
20. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. Kawakami Y; Eliyahu S; Sakaguchi K; Robbins PF; Rivoltini L; Yannelli JR; Appella E; Rosenberg SA J Exp Med; 1994 Jul; 180(1):347-52. PubMed ID: 7516411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]